NO130400B - - Google Patents
Download PDFInfo
- Publication number
- NO130400B NO130400B NO01242/70*[A NO124270A NO130400B NO 130400 B NO130400 B NO 130400B NO 124270 A NO124270 A NO 124270A NO 130400 B NO130400 B NO 130400B
- Authority
- NO
- Norway
- Prior art keywords
- groups
- isoxazolidine
- grams
- alkoxy
- carbon atoms
- Prior art date
Links
- 238000000034 method Methods 0.000 claims description 7
- 125000004423 acyloxy group Chemical group 0.000 claims description 5
- 150000001263 acyl chlorides Chemical class 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 150000002546 isoxazolidines Chemical class 0.000 claims description 4
- CIISBYKBBMFLEZ-UHFFFAOYSA-N 1,2-oxazolidine Chemical compound C1CNOC1 CIISBYKBBMFLEZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000005904 alkaline hydrolysis reaction Methods 0.000 claims description 2
- 125000001477 organic nitrogen group Chemical group 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 10
- 230000000694 effects Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- HPIVVOQIZYNVJE-UHFFFAOYSA-N 1,2-oxazolidin-2-ium;chloride Chemical compound Cl.C1CNOC1 HPIVVOQIZYNVJE-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 230000009194 climbing Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- FGPUFXOHYFCMIN-UHFFFAOYSA-N (3,4-dimethoxyphenyl)-(1,2-oxazolidin-2-yl)methanone Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)N1OCCC1 FGPUFXOHYFCMIN-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- CSLJPCFAMJCBQW-UHFFFAOYSA-N [2,6-dimethoxy-4-(1,2-oxazolidine-2-carbonyl)phenyl] acetate Chemical compound C(C)(=O)OC1=C(C=C(C(=O)N2OCCC2)C=C1OC)OC CSLJPCFAMJCBQW-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- -1 nitrogen-containing organic base Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- GUYBWIMXUDUWPX-UHFFFAOYSA-N (4-carbonochloridoyl-2,6-dimethoxyphenyl) acetate Chemical compound COC1=CC(C(Cl)=O)=CC(OC)=C1OC(C)=O GUYBWIMXUDUWPX-UHFFFAOYSA-N 0.000 description 1
- SHYLPWMBVMRXID-UHFFFAOYSA-N (4-hydroxy-3,5-dimethoxyphenyl)-(1,2-oxazolidin-2-yl)methanone Chemical compound COC=1C=C(C(=O)N2OCCC2)C=C(C1O)OC SHYLPWMBVMRXID-UHFFFAOYSA-N 0.000 description 1
- BUHYMJLFRZAFBF-UHFFFAOYSA-N 3,4,5-trimethoxybenzoyl chloride Chemical compound COC1=CC(C(Cl)=O)=CC(OC)=C1OC BUHYMJLFRZAFBF-UHFFFAOYSA-N 0.000 description 1
- VIOBGCWEHLRBEP-UHFFFAOYSA-N 3,4-dimethoxybenzoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1OC VIOBGCWEHLRBEP-UHFFFAOYSA-N 0.000 description 1
- LRLKZVMLJBNNPE-UHFFFAOYSA-N 3-(3,4,5-trimethoxyphenyl)prop-2-enamide Chemical class COC1=CC(C=CC(N)=O)=CC(OC)=C1OC LRLKZVMLJBNNPE-UHFFFAOYSA-N 0.000 description 1
- CJLIOYNRJJHMNP-UHFFFAOYSA-N 3-(4-hydroxy-3,5-dimethoxyphenyl)-1-(1,2-oxazolidin-2-yl)prop-2-en-1-one Chemical compound COC1=C(O)C(OC)=CC(C=CC(=O)N2OCCC2)=C1 CJLIOYNRJJHMNP-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- XUPSCTMGCXAJGL-UHFFFAOYSA-N [2,6-dimethoxy-4-[3-(1,2-oxazolidin-2-yl)-3-oxoprop-1-enyl]phenyl] acetate Chemical compound COC1=C(OC(C)=O)C(OC)=CC(C=CC(=O)N2OCCC2)=C1 XUPSCTMGCXAJGL-UHFFFAOYSA-N 0.000 description 1
- NIWUDNDULAYEIK-UHFFFAOYSA-N [4-(3-chloro-3-oxoprop-1-enyl)-2,6-dimethoxyphenyl] acetate Chemical compound COC1=CC(C=CC(Cl)=O)=CC(OC)=C1OC(C)=O NIWUDNDULAYEIK-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000006400 anxiety behaviour Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003010 neurosedative effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- SQMCFUSVGSBKFK-UHFFFAOYSA-M sodium;5-(cyclohexen-1-yl)-1,5-dimethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].O=C1N(C)C(=O)[N-]C(=O)C1(C)C1=CCCCC1 SQMCFUSVGSBKFK-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1600069 | 1969-04-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO130400B true NO130400B (es) | 1974-08-26 |
Family
ID=11148429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO01242/70*[A NO130400B (es) | 1969-04-24 | 1970-04-03 |
Country Status (13)
| Country | Link |
|---|---|
| AT (1) | AT296294B (es) |
| BE (1) | BE748711A (es) |
| BR (1) | BR6915476D0 (es) |
| CH (1) | CH541570A (es) |
| DE (1) | DE2019659A1 (es) |
| ES (1) | ES378999A1 (es) |
| FI (1) | FI49305C (es) |
| FR (1) | FR2042369B1 (es) |
| GB (1) | GB1243767A (es) |
| IL (1) | IL34190A (es) |
| NL (1) | NL146497B (es) |
| NO (1) | NO130400B (es) |
| SE (1) | SE349584B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3853903A (en) * | 1972-08-17 | 1974-12-10 | Lepetit Spa | Substituted 2 -benzoylisoxazolidines |
-
1969
- 1969-12-19 BR BR215476/69A patent/BR6915476D0/pt unknown
-
1970
- 1970-03-20 GB GB03637/70A patent/GB1243767A/en not_active Expired
- 1970-03-26 FI FI700871A patent/FI49305C/fi active
- 1970-03-29 IL IL34190A patent/IL34190A/xx unknown
- 1970-04-03 NO NO01242/70*[A patent/NO130400B/no unknown
- 1970-04-09 BE BE748711D patent/BE748711A/xx unknown
- 1970-04-16 NL NL707005470A patent/NL146497B/xx unknown
- 1970-04-22 AT AT368570A patent/AT296294B/de not_active IP Right Cessation
- 1970-04-23 CH CH612170A patent/CH541570A/de not_active IP Right Cessation
- 1970-04-23 SE SE05641/70A patent/SE349584B/xx unknown
- 1970-04-23 FR FR707014841A patent/FR2042369B1/fr not_active Expired
- 1970-04-23 DE DE19702019659 patent/DE2019659A1/de active Pending
- 1970-04-24 ES ES378999A patent/ES378999A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2042369B1 (es) | 1973-06-08 |
| NL146497B (nl) | 1975-07-15 |
| IL34190A0 (en) | 1970-08-19 |
| AT296294B (de) | 1972-02-10 |
| NL7005470A (es) | 1970-10-27 |
| FI49305B (es) | 1975-01-31 |
| GB1243767A (en) | 1971-08-25 |
| CH541570A (de) | 1973-09-15 |
| IL34190A (en) | 1974-03-14 |
| ES378999A1 (es) | 1973-01-16 |
| BE748711A (fr) | 1970-09-16 |
| DE2019659A1 (de) | 1970-10-29 |
| BR6915476D0 (pt) | 1973-02-08 |
| FR2042369A1 (es) | 1971-02-12 |
| SE349584B (es) | 1972-10-02 |
| FI49305C (fi) | 1975-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3963729A (en) | Pharmacologically active pyridine derivatives | |
| US2831027A (en) | Isocamphane compounds and processes for preparing the same | |
| EP0007019A1 (de) | Neue 5-Phenylpyrazol-Derivate und ihre Salze; Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| EP0005231A2 (de) | Isochinolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
| EP0133530A2 (de) | 1,6-Naphthyridinon-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| CH506525A (de) | Verfahren zur Herstellung von aromatischen Äthern | |
| NO130400B (es) | ||
| NO300839B1 (no) | Nye 2-cyano-3-hydroksy-propenamider og farmasöytiske preparater inneholdende slike | |
| NO152786B (no) | Fremgangsmaate ved fremstilling av 10,11-dihydro-5h-dibenzo-(a,d)-cyclohepten-5,10-iminer | |
| NO149314B (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive imidazoisokinolindioner | |
| NO155056B (no) | Sprengstoff. | |
| DD154487A5 (de) | Verfahren zur herstellung von 1-benzoxepin-5(2h)-on-derivaten | |
| CH617188A5 (es) | ||
| NO162017B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-aryl-alfa-pyridylalkansyrederivater. | |
| US4013667A (en) | 2,2-Diaryl-3-(1-azabicyclo[2.2.2]oct-2-yl)propionamides and intermediates thereto | |
| CH637951A5 (de) | 3-pyrazol-1-yl-pyridazin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittelpraeparate. | |
| Shaw et al. | Analogs of Aspergillic Acid. III. Synthesis of Cyclic Hydroxamic Acids with a Five-membered Ring | |
| NO770014L (no) | Fremgangsm}te til fremstilling av hydroazinderivater. | |
| CH669196A5 (de) | Triazolopyrimidine und verfahren zu ihrer herstellung. | |
| CH641457A5 (de) | Azepino(1,2,3-lm)-beta-carbolin-verbindungen, verfahren zu deren herstellung und arzneimittel, welche die verbindungen enthalten. | |
| US3378592A (en) | Process for the production of 3, 4-dihydroxybenzyloxyaminehydrobromide | |
| DE2151487A1 (de) | Pharmazeutische Massen | |
| EP0004322A1 (de) | Isochinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln | |
| SU1329620A3 (ru) | Способ получени производных изохинолина или их фармацевтически пригодных аддитивных кислых солей | |
| CH460773A (de) | Verfahren zur Herstellung von substituierten 3-(3-Hydroxyphenyl)-1-phenacyl-piperidinen |